drugset / Trial / NCT04465123

Early Sequential Nephron Blockade in Acute Heart Failure Patients: A Randomised, Controlled Study

NCT04465123

Phase 3 Unknown 100 enrolled Chiang Mai University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to demonstrate the efficacy of sequential nephron blockade by adding hydrochlorothiazide or spironolactone on intravenous furosemide compared to intravenous furosemide alone in the treatments of volume overload in patients with acute heart failure who have diuretic resistance from furosemide stress test.

Timeline

Start
2020-08-13
Primary completion
2022-07-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 50 mg Oral
Subject Spironolactone Small molecule 100 mg Oral